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Figure 1A:  October 2010: 2.0 x 3.0 cm pink to 
purple plaque on the right breast.  
Figure 1B:  December 2011: 10.0 x 14.0 cm pink 
to purple, indurated plaque on the right breast.
Figure 2A:  H&E October 2010: There are a 
number of ectatic vessels with plump small 
endothelial cells surrounded by a patchy mixed 
cell infiltrate.  The infiltrate is composed of 
lymphocytes, histioctyes, and a rare eosinophil.  
Extravasated erythrocytes are present.
Figure 2B:  H&E December 2011: 
Monomorphic endothelial cells with no 
cytologic atypia and no mitoses.  There is 
a conspicuous population of lymphocytes 
clustered within and around the vessels. 
distinguishing	atypical	vascular	lesions	(AVLs)	from	early	angiosarcoma.		An	
established	treatment	protocol	is	needed	for	patients	that	fall	into	this	category.
AVLs	typically	present	in	women	in	their	50s	that	have	received	breast-
conserving	surgery,	in	conjunction	with	an	average	treatment	of	40-60	Gy	
cumulative	radiation	dose.		Clinically,	these	lesions	tend	to	be	smaller,	
well	circumscribed,	and	symmetrical.		The	post	radiation	interval	for	the	
development	of	AVLs	is	notably	shorter	compared	to	frank	angiosarcoma.		
The	time	to	presentation	for	AVLs	is	approximately	3	years	compared	to	
angiosarcoma,	which	is	approximately	6	years.		This	has	led	to	the	hypothesis	
that	AVLs	and	angiosarcoma	are	part	of	a	continuous	spectrum	of	vascular	
lesions,	and	that	AVLs	represent	a	precursor	lesion.		
Histopathologic	analysis	of	AVLs	versus	angiosarcoma	can	be	difficult	due	
to	many	different	overlapping	features.		To	date,	angiosarcoma	has	been	
histopathologically	identified	by	anastomosing	vascular	channels	lined	by	
prominent	endothelial	cells	with	nuclear	hyperchromasia	and	hobnailing.		
Dissection	of	dermal	collagen	and	involvement	of	the	subcutaneous	tissue	can	
occur	in	conjunction	with	necrosis	or	“blood	lakes”.		AVLs,	in	contrast,	appear	
well	circumscribed,	wedge-shaped,	and	tend	to	involve	only	the	superficial	to	
mid	dermis.		Recently,	fluorescence	in	situ	hybridization	(FISH)	has	been	able	
to	distinguish	AVLs	from	angiosarcoma	by	the	presence	of	MYC	amplification,	
although	repeat	testing	on	multiple	biopsy	sites	may	be	needed	for	consistent	
results.			
No	definitive	criteria	are	available	to	adequately	predict	whether	AVLs	will	
develop	into	angiosarcoma	or	may	continue	to	follow	a	benign	course.		Recent	
attempts	at	sub-classifying	lesions	with	similar	histopathologic	findings	into	
two	categories	(i.e.	lymphatic	appearing	versus	capillary	appearing	lesions)	
has	not	been	found	to	be	a	definitive	means	of	distinguishing	AVLs	of	a	more	
aggressive	nature,	or	those	that	may	develop	into	angiosarcoma.		Analysis	of	
new	cases	with	long	term	follow-up	is	needed	to	further	analyze	the	spectrum	of	
these	lesions,	leading	to	an	appropriate	and	accepted	treatment	algorithm	in	the	
future.					
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